Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX–Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective–Prospective StudyAntonio Coppola, Annarita Tagliaferri, Rossana Rossi et al.|Journal of Clinical Medicine|2024Cited by 6
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center studySara Bigliardi, Fabio Forghieri, Monica Morselli et al.|Annals of Hematology|2015Cited by 5
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trialsMaddalena Alessandra Wu, Cinzia Del Giovane, Riccardo Colombo et al.|Internal and Emergency Medicine|2023Cited by 3